Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21098032rdf:typepubmed:Citationlld:pubmed
pubmed-article:21098032lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:21098032lifeskim:mentionsumls-concept:C1364684lld:lifeskim
pubmed-article:21098032lifeskim:mentionsumls-concept:C1182610lld:lifeskim
pubmed-article:21098032lifeskim:mentionsumls-concept:C1413549lld:lifeskim
pubmed-article:21098032lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:21098032pubmed:issue3lld:pubmed
pubmed-article:21098032pubmed:dateCreated2011-1-17lld:pubmed
pubmed-article:21098032pubmed:abstractTextElevated extracellular solute concentration (hyperosmotic stress) perturbs cell function and stimulates cell responses by evoking MAPK cascades and activating AP-1 transcription complex resulting in alterations of gene expression, cell cycle arrest, and apoptosis. The results presented here demonstrate that hyperosmotic stress elicited increases in ATF-2 phosphorylation through a novel Polo-like kinase 3 (Plk3) pathway in human corneal epithelial (HCE) cells. We found in hyperosmotic stress-induced HCE cells that Plk3 transferred to the nuclear compartment and was colocalized with ATF-2 in nuclei. Kinase activity of Plk3 was significantly activated by hyperosmotic stimulation. Further downstream, active Plk3 phosphorylated ATF-2 at the Thr-71 site in vivo and in vitro. Overexpression of Plk3 and its mutants enhanced hyperosmotic stress-induced ATF-2 phosphorylation. In contrast, suppression of Plk3 by knocking down Plk3 mRNA effectively diminished the effect of hyperosmotic stress-induced ATF-2 phosphorylation. The effect of hyperosmotic stress-induced activation of Plk3 on ATF-2 transcription factor function was also examined in CRE reporter-overexpressed HCE cells. Our results for the first time reveal that hyperosmotic stress can activate the Plk3 signaling pathway that subsequently regulates the AP-1 complex by directly phosphorylating ATF-2 independent from the effects of JNK and p38 activation.lld:pubmed
pubmed-article:21098032pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:languageenglld:pubmed
pubmed-article:21098032pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:citationSubsetIMlld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21098032pubmed:statusMEDLINElld:pubmed
pubmed-article:21098032pubmed:monthJanlld:pubmed
pubmed-article:21098032pubmed:issn1083-351Xlld:pubmed
pubmed-article:21098032pubmed:authorpubmed-author:JayMMlld:pubmed
pubmed-article:21098032pubmed:authorpubmed-author:RohJ RJRlld:pubmed
pubmed-article:21098032pubmed:authorpubmed-author:WangLingLlld:pubmed
pubmed-article:21098032pubmed:authorpubmed-author:PaytonReidRlld:pubmed
pubmed-article:21098032pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21098032pubmed:day21lld:pubmed
pubmed-article:21098032pubmed:volume286lld:pubmed
pubmed-article:21098032pubmed:ownerNLMlld:pubmed
pubmed-article:21098032pubmed:authorsCompleteYlld:pubmed
pubmed-article:21098032pubmed:pagination1951-8lld:pubmed
pubmed-article:21098032pubmed:dateRevised2011-8-1lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:meshHeadingpubmed-meshheading:21098032...lld:pubmed
pubmed-article:21098032pubmed:year2011lld:pubmed
pubmed-article:21098032pubmed:articleTitleHyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells.lld:pubmed
pubmed-article:21098032pubmed:affiliationDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Torrance, California 90502, USA.lld:pubmed
pubmed-article:21098032pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21098032pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:1386entrezgene:pubmedpubmed-article:21098032lld:entrezgene
entrez-gene:1263entrezgene:pubmedpubmed-article:21098032lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21098032lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21098032lld:entrezgene